What inomed does

inomed Medizintechnik GmbH is a privately held German medical device manufacturer founded in 1991 and headquartered in Emmendingen, Germany, specializing in intraoperative neuromonitoring (IONM), functional neurosurgery, pain therapy, and ablation systems. The company sells capital equipment platforms including the ISIS IOM family (Xpress, Xpert, Xpert plus), the mobile C2 Xplore system, the ISIS MER microelectrode recording system, multiple stereotaxy systems (SUSy, ZD, RM), RF lesion generators, the C3 CryoSystem for cryoanalgesia, and the VIVA RF ablation system, supported by integrated software platforms (NeuroExplorer 8 Synergy, inomed Planning System) and consumable accessories. Its clinical applications span neurosurgery, spine surgery, thyroid surgery (including ALM and FLUOBEAM LX autofluorescence), ENT, vascular surgery, pelvic surgery, deep brain stimulation, and chronic pain treatment. The company serves hospitals, academic medical centers, and surgical clinics across Germany, France, Italy, the UK, the USA, and Poland via wholly-owned regional subsidiaries, complemented by the iNCU clinical IONM service network operating in nine European countries.

The business model combines one-time capital equipment sales with recurring revenue from accessories and consumables (stimulation probes, electrodes, cryoprobes, cannulas, TC electrodes) sold through the shop.inomed.com e-commerce platform and quote-based direct sales. Professional services revenue is generated through the iNCU remote and on-site clinical neuromonitoring service, and managed services revenue from technical support, training, and after-sales. Pricing is not publicly disclosed and is negotiated B2B with account registration required for commercial customers. Marketing and distribution rely on direct enterprise field sales, regional partner distributors (e.g., STARMED in the UK, Genesysmed in Latin America), participation in medical congresses, sponsored training programs (e.g., ARKANA Forum, Universitätsklinikum Heidelberg), and platinum-level sponsorship of the Eurocrine endocrine surgery database.

The company operates in the global nerve monitoring market valued at USD 1.58 billion in 2025 and projected to reach USD 2.83 billion by 2034 at a 6.70% CAGR, competing alongside Medtronic and NuVasive. Ownership is founder/management-controlled via authorized representatives Mariusz Gruchala and Jörg Wipfler, with no disclosed external investors, funding rounds, or M&A activity, reflecting a long-established, privately-held mid-market MedTech profile.

Name

inomed

Legal name

inomed Medizintechnik GmbH

Website

https://inomed.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

101–250 employees

Short description

inomed Medizintechnik GmbH is a German medical device manufacturer (founded 1991) that develops and sells intraoperative neuromonitoring systems, stereotactic frames, pain therapy devices, and ablation systems to hospitals and clinics across Europe and the US.

Ownership category

akta.pro rank

Product category

Intraoperative Neuromonitoring Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)

Keywords

• Intraoperative neuromonitoring
• Functional neurosurgery systems
• Pain therapy devices
• Radiofrequency ablation equipment
• Stereotactic neurosurgery systems

Headquarters

HQ city

Emmendingen

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of neuromonitoring systems, pain therapy devices, stereotactic systems, and associated hardware. Products include ISIS IOM family, C2 Xplore, C3 CryoSystem, RF lesion generators, stereotactic systems, and ISIS MER systems.
2. Accessories and Consumables: Sale of accessories and disposables including stimulation probes, electrodes, cannulas, cryoprobes, TC electrodes, cables, and other consumables for medical procedures. Products sold through e-commerce platform shop.inomed.com.
3. Clinical Services (iNCU): Intraoperative neuromonitoring clinical services providing trained personnel for surgical monitoring during procedures. Service available across multiple European countries.
4. Service and Support: Technical support, training, and after-sales service for medical device systems.
5. Literature and Publications: Sale of specialized literature including application notes and specialized publications such as the Intraoperative Neuromonitoring book (ISBN 978-3-95466-501-3) and system-specific application documentation.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

inomed develops and manufactures medical devices and systems for intraoperative neuromonitoring (IONM), functional neurosurgery, pain therapy, and radiofrequency ablation. The portfolio includes the ISIS IOM product family, C2 Xplore mobile IONM system, ISIS MER system, stereotactic systems (SUSy, ZD, RM), RF lesion generators, C3 CryoSystem, and the FLUOBEAM LX fluorescence imager, complemented by clinical IONM services delivered through the iNCU network across Europe.

Product overview

inomed Medizintechnik GmbH offers a comprehensive portfolio of medical technology solutions for intra- and perioperative protection of the nervous system, founded in 1991. The product portfolio consists of multiple integrated systems: (1) Intraoperative Neuromonitoring (IONM) systems including C2 Xplore mobile system and the ISIS IOM product family (ISIS Xpress, ISIS Xpert, ISIS Xpert plus) with NeuroExplorer software for real-time neurophysiological monitoring during surgery; (2) Pain Therapy solutions comprising the C3 CryoSystem for cryoanalgesia and RF Lesion Generators for radiofrequency thermolesion procedures; (3) Ablation systems including VIVA RF and VIVA multi RF Systems for radiofrequency ablation; (4) Functional Neurosurgery equipment including stereotaxy systems (SUSy, ZD, RM), ISIS MER System for microelectrode recording, inomed Planning System software, and LG2-sEEG RF-Läsionsgenerator; (5) FLUOBEAM LX fluorescence imaging; and (6) the iNCU remote monitoring service. The products are complemented by specialized accessories for each application area.

Differentiator

Problem solved

Functional benefit

Products and services

• C2 Xplore Mobile intraoperative neuromonitoring (IONM) system for real-time monitoring of neural structures during surgical procedures, targeted at hospitals and surgical teams.
• ISIS IOM Produktfamilie Comprehensive IONM product family including ISIS Xpress, ISIS Xpert, ISIS Xpert plus, and ISIS IOM NeuroExplorer software for intraoperative neurophysiological monitoring in hospitals.
• ISIS Neurostimulator Neurostimulator for intraoperative neuromonitoring applications used by surgical teams.
• ISIS MER System Microelectrode recording system providing hardware and software for target point diagnostics in intraoperative functional neurosurgery, including deep brain stimulation.
• NeuroExplorer 8.1 Latest-generation software platform for advanced intraoperative neurophysiological monitoring with enhanced ease of use, paired with the ISIS IOM system.
• NeuroExplorer 8 Synergy Software platform combining MER, LFP and MEP technologies for advanced intraoperative neurophysiological monitoring with integrated data analysis.
• C3 CryoSystem Cryotherapy device for cryoanalgesia with integrated electrical stimulation for precise nerve localization, using CO2 or N2O via the Joule-Thomson principle for chronic pain treatment.
• RF Läsionsgeneratoren Radiofrequency lesion generators for pain therapy using thermolesion in minimally invasive pain treatment procedures.
• VIVA RF System Radiofrequency ablation system for minimally invasive ablation procedures including thyroid nodules and uterine fibroids, used in hospitals and fertility clinics.
• VIVA multi RF System Multi-channel radiofrequency ablation system for expanded ablation applications.
• SUSy Stereotaxie-System Stereotactic Ultralight System for functional neurosurgery offering versatility, flexibility and precision for brain targeting procedures including biopsy, lesioning, and electrode placement.
• ZD-Stereotaxie-System Stereotaxy system for functional neurosurgery procedures requiring precise brain targeting.
• RM-Stereotaxie-System Stereotaxy system for functional neurosurgery targeting procedures.
• inomed Planning System (iPS) Planning software for functional neurosurgery procedures including deep brain stimulation and stereotactic interventions.
• LG2-sEEG RF-Läsionsgenerator RF lesion generator specifically designed for stereoelectroencephalography (sEEG) procedures in functional neurosurgery.
• FLUOBEAM LX Fluorescence imaging device for autofluorescence visualization, particularly used for parathyroid gland identification during thyroid surgery.
• MikroSondenVorschub (MSV) Microprobe advancement device for precise electrode placement in functional neurosurgery procedures.
• iNCU Clinical Service Clinical intraoperative neuromonitoring service providing remote monitoring capabilities and trained personnel for surgical procedures across Denmark, Germany, France, Italy, Norway, Poland, Sweden, Switzerland, and the United Kingdom.

Quantifiable outcome

• 219,363 endocrine surgeries recorded in Eurocrine database supported by inomed
• +1 more outcomes

Named customers4 records

Segments8 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core and minor.

• STARMEDcoreChannel Partner/ Reseller/ DistributorSTARMED serves as exhibitor for inomed UK at medical congresses such as ESHRE (European Society of Human Reproduction and Embryology) 42nd Annual Meeting in London. STARMED exhibits the STARMED VIVA RF System, an innovative fertility-preserving treatment option for women suffering from uterine fibroids using minimally invasive radiofrequency ablation technology.
• GenesysmedminorChannel Partner/ Reseller/ DistributorLocal partner for inomed at the 4th Congress of the Latin American Pain Society (LAPS) in São Paulo, Brazil. Genesysmed supports inomed as a sponsor at this pain treatment congress.
• EurocrinecoreGTM or Marketing PartnerInomed is platinum sponsor of the Eurocrine database, which contains data from 219,363 endocrine surgeries including 7,171 thyroid operations in 2026. Eurocrine enables endocrine professionals to share insight and experience across Europe (from Cyprus to Norway). This partnership supports inomed's Expertise in Thyroid portfolio.
• Offenburg University of Applied SciencesminorOthersInomed participates in the 'startING' programme at Offenburg University of Applied Sciences, an engineering orientation semester where first-year students explore various companies. Students receive insights into working at inomed through presentations from Research, Development and Regulatory Affairs departments.
• ARKANA ForumminorOthersEducational service partnership through ARKANA Forum for continuing medical education and training programs related to inomed products and applications.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Brainlab: Munich-based software and hardware platform for functional neurosurgery and stereotactic procedures. Closely comparable to inomed in DBS targeting, stereotactic planning, and intraoperative neurophysiology, with overlapping customer base in academic neurosurgery centers.
• Natus Medical: US-based neurodiagnostic and monitoring company cited as a key nerve monitoring competitor. Competes with inomed across IONM, EMG, and intraoperative neurophysiology monitoring systems for hospital and clinical neurology customers.
• Nihon Kohden: Japanese neurodiagnostic and IONM specialist identified alongside inomed as a key player in the global nerve monitoring market. Direct overlap in intraoperative neurophysiological monitoring hardware and consumables for surgical applications.
• Integra LifeSciences: Neurosurgery-focused MedTech with broad portfolios in surgical instruments, neuromonitoring, and tissue ablation. Direct overlap with inomed across neurosurgical instrumentation, IONM, and cranial nerve monitoring applications.

Broad incumbents

• Stryker: Diversified surgical MedTech with neurosurgery, spine, and surgical navigation offerings. Competes with inomed at the hospital level through broader surgical platform bundles that can include IONM-adjacent navigation and spine instrumentation.
• Abbott (St. Jude Medical): Large neuromodulation incumbent offering DBS, SCS, and PNS implants. While primarily implant-focused, Abbott's functional neurosurgery ecosystem competes with inomed's stereotactic, MER, and intraoperative monitoring workflows around DBS procedures.
• Globus Medical (formerly NuVasive): Major spine and neuromonitoring company with ~15% nerve monitoring market share. Competes directly with inomed's spine IONM (pedicle screw stimulation, scoliosis monitoring) and intraoperative neurophysiology offerings as part of a broader spine surgery platform.
• Medtronic: Global MedTech leader holding ~18% share of the nerve monitoring systems market. Operates broadly across neuromodulation (DBS, SCS, PNS implants), IONM, and surgical navigation — directly overlapping with inomed's functional neurosurgery and IONM portfolio while offering far broader scale.
• Boston Scientific: Global MedTech with significant neuromodulation business (DBS, SCS). Operates across pain therapy and functional neurosurgery — directly adjacent to inomed's RF lesion generator and cryoanalgesia pain therapy portfolio as well as DBS support.

Emerging players

• ClearPoint Neuro: Focused neuro-navigation and drug delivery platform for functional neurosurgery and DBS procedures. Smaller, specialized player targeting similar clinical workflows as inomed's stereotactic and MER portfolio, particularly around gene therapy delivery and DBS targeting.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInde.linkedin.com/company/inomed

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about inomed